FDA approved revolutionary immunotherapy for blood cancer patients

Singapore – The U.S. Food and Drug Administration (FDA) announced the approval of a new, cutting-edge gene therapy...

September 1, 2017 | Friday | News
New treatment for adults with relapsed or refractory acute lymphoblastic leukemia

Singapore- The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of ad...

August 18, 2017 | Friday | News
Swift announces the highest throughput single-cell methyl-seq library preparation method

Singapore - Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (N...

August 14, 2017 | Monday | News
Speeding up drug discovery process with Artificial Intelligence

Singapore: It’s estimated that, on average, to bring one new drug to the market can take 1,000 people, 12-15 years...

August 10, 2017 | Thursday | Opinion
Xarelto proven to be highly effective stroke prevention in patients with AF

Singapore - Cardiovascular diseases including heart diseases and stroke account for one-third of deaths (nearly 18 milli...

August 1, 2017 | Tuesday | News
Takeda, Tesaro ink strategic deal to co-develop and commercialize cancer drug

Japanese pharma giant Takeda pharmaceuticals has entered into a strategic licensing deal with US’s Tesaro  fo...

August 1, 2017 | Tuesday | News
CARB-X announces funding to speed treatments for the world’s deadliest super bugs

A year since launching, the international partnership CARB-X announced its second round of antibiotic research and ...

August 1, 2017 | Tuesday | News
Jim Spavins appointed to the advisory board of Catalent Applied Drug Delivery Institute

The Catalent Applied Drug Delivery Institute has announced Jim Spavins to their advisory board. He has over 36 years of...

July 31, 2017 | Monday | News
FROM TRADITIONAL TO ADVANCED: Drug delivery market on the growth curve in Asia

The field of drug delivery is highly interdisciplinary. This science of delivering a pharmaceutical compound in the huma...

July 26, 2017 | Wednesday | Analysis
Korean Pharma Association mulls on use of AI to speed drug discovery

Singapore: In a bid to spur the country’s drug development and research, South Korea’s leading biopharmaceu...

July 25, 2017 | Tuesday | News
FDA approves GSK’s new self-injectable formulation for systemic lupus erythematosus

Singapore - GSK announced that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulatio...

July 24, 2017 | Monday | News
FDA approves new treatment to reduce the risk of breast cancer returning

Singapore - The U.S. Food and Drug Administration approved Nerlynx (neratinib) for the extended adjuvant treatment of ea...

July 18, 2017 | Tuesday | News
U.S. FDA approves Janssen’s TREMFYA for the treatment of moderate to severe plaque psoriasis

Janssen Biotech, Inc. has announced that the U.S. Food and Drug Administration (FDA) approved TREMFYA (guselkumab) for t...

July 17, 2017 | Monday | News
Kolon Life Science wins license for gene therapy drug

South Korea based Kolon Life Science has won a license to sell the nation’s first gene therapy drug for osteoarthr...

July 17, 2017 | Monday | News
Exscientia inks €37m contract with GSK

GlaxoSmithKline has secured access to Ex Scientia Ltd (Exscientia)’s artificial intelligence (AI)-driven drug...

July 3, 2017 | Monday | News
Promethazine by Strides Shasun approved by USFDA

Strides Shasun has recently received an approval from the United States Food & Drug Administration (USFDA) for Prome...

July 3, 2017 | Monday | News
Amgen’s uncontrolled LDL cholesterol lowering drug available in Singapore

Singapore – Amgen, a US based biotechnology company, announced the availability of Repatha(evolocumab), the first ...

July 3, 2017 | Monday | News
Strategic alliance between Alma Bio Therapeutics and Delphi Genetics on Plasmid DNA drugs

Alma Bio Therapeutics SAS (Alma) and Delphi Genetics SA recently announced that they are taking their strategic alliance...

June 27, 2017 | Tuesday | News